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Abstract
A hallmark of Alzheimer’s disease (AD) is the rearrangement of the b-amyloid (Ab) peptide to a non-native conformation
that promotes the formation of toxic, nanoscale aggregates. Recent studies have pointed to the role of sample preparation
in creating polymorphic fibrillar species. One of many potential pathways for Ab toxicity may be modulation of lipid
membrane function on cellular surfaces. There are several mutations clustered around the central hydrophobic core of Ab
near the a-secretase cleavage site (E22G Arctic mutation, E22K Italian mutation, D23N Iowa mutation, and A21G Flemish
mutation). These point mutations are associated with hereditary diseases ranging from almost pure cerebral amyloid
angiopathy (CAA) to typical Alzheimer’s disease pathology with plaques and tangles. We investigated how these point
mutations alter Ab aggregation in the presence of supported lipid membranes comprised of total brain lipid extract. Brain
lipid extract bilayers were used as a physiologically relevant model of a neuronal cell surface. Intact lipid bilayers were
exposed to predominantly monomeric preparations of Wild Type or different mutant forms of Ab, and atomic force
microscopy was used to monitor aggregate formation and morphology as well as bilayer integrity over a 12 hour period.
The goal of this study was to determine how point mutations in Ab, which alter peptide charge and hydrophobic character,
influence interactions between Ab and the lipid surface. While fibril morphology did not appear to be significantly altered
when mutants were prepped similarly and incubated under free solution conditions, aggregation in the lipid membranes
resulted in a variety of polymorphic aggregates in a mutation dependent manner. The mutant peptides also had a variable
ability to disrupt bilayer integrity.
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Ab have been known for some time [5,6]. By subtle alterations in
fibril growth conditions, two structurally distinct polymorphic
fibrils of Ab (1–40) were formed that displayed significantly
different levels of toxicity to neuronal cell cultures [7]. Another
fibrillar polymorph of Ab was identified by using fibrils extracted
from AD brains as seeds [8]. Recent studies have demonstrated
that variations in Ab (1–40) sample preparation can result in at
least five structurally-distinct fibrillar aggregates in vitro [9].
Collectively, these studies point to the notion that aggregate
polymorphism may contribute to variations in AD.
A potential environmental factor influencing Ab aggregate
formation is the presence of lipid surfaces. In particular, it has
been hypothesized that a potential pathway for Ab toxicity may lie
in its ability to modulate lipid membrane function. Thus,
elucidating the interaction between Ab and membrane lipids
could be critical in understanding potential pathways of Ab
toxicity, especially given the results of studies demonstrating that
changes in membrane composition occur in AD [10,11]. The twodimensional liquid environments provided by lipid bilayers can
profoundly alter protein structure and dynamics by both specific
and nonspecific interactions. General physicochemical membrane

Introduction
The neuropathological and neurochemical hallmarks of Alzheimer’s disease (AD) include: synaptic loss and selective neuronal cell
death; decreases in markers for certain neurotransmitters; and
abnormalities in neurons and their processes (neurofibrillary tangles
comprised of Tau and dystrophic neurites) as well as in the
extracellular space (cerebrovascular, diffuse, and neuritic plaques composed predominantly of the amyloidogenic peptide Ab) [1,2].
Ab is formed by endoproteolytic cleavage of a single-transmembrane, receptor-like protein termed the b-amyloid precursor protein
(APP) (Fig. 1). All AD patients develop neuritic plaques in brain
regions subserving memory and cognition. These plaques consist of
extracellular masses of Ab filaments and other plaque associated
proteins (e.g. apoE, apoJ, inflammatory molecules) which are
intimately associated with dystrophic dendrites and axons, activated
microglia, and reactive astrocytes [3].
It has been well established that many amyloid forming peptides
have the ability to aggregate into a variety of morphologically
distinct and stable fibril structures [4]. At a gross morphological
level, this ability to form distinct polymorphic fibril structures of
PLoS ONE | www.plosone.org
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Results
Free solution aggregation of Wild Type and mutant
forms of Ab results in similar fibril morphologies
To compare the resulting morphological features of fibrils
formed by Wild Type and the mutant forms of Ab under free
solution conditions (without the presence of a lipid surface), 20 mM
solutions of Wild Type, Arctic, Italian, Iowa, or Flemish Ab (1–40)
were incubated at 37oC and sampled at various times to check for
the presence of fibrils. To control for the role of sample
preparation and solution conditions, which have been shown to
result in distinct polymorphic fibrillar structures of Wild Type Ab
[9], all samples were prepared via the same protocol [44]. While
the presence of these specific mutations to alter the kinetics of Ab
has been demonstrated, we were interested if, once formed, there
were distinct fibrillar morphologies associated with the different
mutations. Ex situ AFM images and height profiles of fibrils formed
by Wild Type, Arctic, Italian, Iowa, or Flemish Ab (1–40) are
shown in Figure 2. While the time required for fibril formation
varied for Wild Type or mutant forms of Ab, the final fibril
structures formed under these conditions were indistinguishable
based on gross morphological measurements. Fibrils formed from
Wild Type or the mutant forms of Ab (1–40) were 5–8 nm tall,
had similar widths (within the error associated with the finite size
and shape of the AFM tip), and often were twisted together when
the fibril density was high.

Figure 1. Schematic representation of APP processing and
point mutations in Ab. a-secretase-mediated proteolytic cleavage of
APP occurs after residue 687 of APP, b-secretase-mediated cleavage
occurs after residue 671, and c-secretase cleavage at position 711 or
713. Successive cleavage by b-secretase and c-secretase results in the
release of an intact Ab peptide. Several point mutations in APP and Ab
are indicated, including the Arctic, Italian, Iowa, and Flemish mutations,
which were used in this study.
doi:10.1371/journal.pone.0016248.g001

properties, such as phase state, bilayer curvature, elasticity and
modulus, surface charge, and degree of hydration can modulate
these protein/lipid interactions; however, the exact chemical
composition, i.e. extent of acyl chain unsaturation, conformation
and dynamics of lipid headgroups and acyl chains, and protein–
lipid selectivity arising from factors such as the hydrophobic
matching at the protein–lipid interface of the membrane lipids also
plays a role [12]. Importantly for misfolding diseases, these bilayer
properties can not only modulate protein conformation, but also
exert influence on oligomerization state, as numerous studies
indicate substantial enhancement of protein and peptide aggregation in a membrane environment [13,14,15,16,17,18,19,20].
Although lipid bilayers may act to induce aggregation and
fibrillogenesis by providing environments that promote protein
conformation and orientation conducive to assembly into protofibrillar and fibrillar structures [21,22,23,24], cell membranes may
be the direct target of amyloid forming peptides, resulting in cell
death. This may be due to amyloid forming peptides inducing
membrane permeabilization by altering bilayer structure
[21,24,25,26,27] or by forming unregulated pore-like structures
[28].
There are several point mutations associated with familial forms
of AD. We were particularly interested in point mutations clustered
around the central hydrophobic core of Ab (E22G Arctic mutation,
E22K Italian mutation, D23N Iowa mutation, and A21G Flemish
mutation) (Fig. 1). With only the Flemish mutation being an
exception, these missense mutations are not associated with
increased Ab secretion [29,30,31,32,33]. All of these Ab variants,
except the Flemish mutation, have a greater propensity to aggregate
into protofibrils and/or fibrils than wild-type Ab [31,34,35,36,37],
and have been reported to be more toxic to neuroblastoma cells in
vitro [38,39,40,41,42]. Interestingly, these mutations are located at
the end of or directly adjacent to a sequence in Ab (residues 16–21)
that has been identified to have amyloidogenic properties [43]. Due
to their clustering around positions 21–23, these mutations offer a
unique opportunity to correlate toxicity to specific aggregate
conformers, as point mutations alter the rates of Ab aggregation,
fibril formation, interaction with surfaces, and insertion into lipid
bilayers by changing the hydrophobicity or charge following
substitution. Here, we investigate how these point mutations alter
the aggregation of Ab in the presence of supported lipid bilayers.
PLoS ONE | www.plosone.org

Wild Type Ab (1–40) forms distinct aggregates on lipid
membranes leading to membrane disruption
Supported bilayers on mica used in this study were produced
through the fusion of total brain lipid extract (TBLE) vesicles (Fig. 3).
The fusion of lipid vesicles to form supported planar bilayers is wellknown [45]. It has also been documented that supported bilayers
preserve many properties of free membranes such as lateral fluidity
[46]. Furthermore, these TBLE bilayers provide an excellent model
surface for studies aimed at elucidating the interaction of Ab with
lipids as they are comprised of a physiologically relevant ratio of
membrane components, i.e. acidic and neutral phospholipids,
gangliosides, cholesterol, sphingolipids, and isoprenoids. The
formation of a supported bilayer is accelerated under the influence
of the scanning AFM tip, resulting in the quick formation of defectfree model bilayers for use in these studies. Only defect-free TBLE
bilayers, as determined by AFM images, were used to study Ab/
lipid interactions, and observations were limited to these verified
defect-free regions. Once formed, the supported TBLE bilayers
remained stable, i.e. there was no visible roughening or disruption,
for 14–15 hours as assessed by AFM imaging.
Experiments exposing defect-free TBLE bilayers to freshly
prepared Wild Type Ab (1–40) verified previously reported
observations [16]. These experiments also served as controls for
comparison with experiments conducted with mutant forms of Ab
(1–40). To control for any influence of the AFM tip on Ab
aggregation and Ab-induced bilayer disruption, small areas of
bilayer were intermittently scanned. Initially when TBLE bilayers
were exposed to freshly prepared aliquots of a 20 mM solution of
Wild Type Ab (1–40) via injection into the fluid cell, there was little
if any discernable deposition of protein onto the bilayer. With time
(2–4 hours), discrete oligomeric aggregates of Wild Type Ab (1–40)
appeared on, or possibly in, the bilayer (Fig. 4A). These aggregates
were stable and appeared to be relatively immobile, as they
appeared unchanged in several successive AFM images taken over
several hours. After ,9–12 hours of exposure to Wild Type Ab (1–
40), the bilayer developed large regions of increased bilayer
roughness, indicating disruption of the bilayer’s structural integrity
2
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Figure 2. Wild Type and mutant Ab fibril morphologies. A series of ex situ AFM images demonstrating the fibrillar morphologies associated
with (A) Wild Type, (B) Arctic (C) Italian, (D) Iowa, and (E) Flemish Ab aggregates. For all examples, color lines in the AFM image correspond to the
profile of the same color presented to the right of each image.
doi:10.1371/journal.pone.0016248.g002

Type Ab (1–40) (Fig. 5A) appeared on the lipid surface. These
oligomers typically were observed within 1–2 hours after injection,
exhibiting comparable stability and immobility to those formed
from Wild Type. These oligomers also increased in number with
time. Within ,6–8 hours of exposure to Arctic Ab, vast areas of
increased bilayer roughness were observed; however, these areas
were not associated with the co-localized rigid fibrillar aggregates
as was the case with Wild Type (Fig. 5B). While these areas
appeared to be populated by discrete oligomeric aggregates, there
was a large number of morphologically indistinguishable oligomers
that were not associated with disrupted bilayer structure.
Elongated fibrillar aggregates were also observed within 6–8 hours
of addition of Arctic Ab (1–40) to the lipid bilayer. While many of

induced by the presence of Wild Type Ab (1–40) (Fig. 4B–D). These
areas of increased roughness were predominately associated with
the presence of elongated, rigid fibrillar aggregates as evidence by
their straight morphology. While the vast majority (,95%) of
observed fibrils was co-localized with distinctly disrupted bilayer
surfaces, some fibrillar aggregates of Wild Type Ab (1–40) were not
associated with obvious adjacent areas of bilayer roughening.

Point mutations in Ab (1–40) alter the aggregate forms
observed on lipid bilayers
When TBLE bilayers were exposed to a freshly prepared
aliquots of 20 mM solution of Arctic Ab (1–40), small oligomeric
aggregates similar in morphology to those associated with Wild

Figure 3. Formation of total brain lipid extract (TBLE) bilayer. A sequence of time-lapse in situ AFM images that demonstrate the formation of
a supported TBLE bilayer on mica via vesicle fusion is shown. Initially, round bilayer patches appeared on mica as vesicles encountered the surface.
With time, these patches gradually fused to form a defect-free bilayer patch, which provided an excellent model surface for studying the aggregation
of Ab and its mutant forms.
doi:10.1371/journal.pone.0016248.g003

PLoS ONE | www.plosone.org
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Figure 4. Representative in situ AFM images of Wild Type Ab (1–40) aggregate formation on supported TBLE lipid bilayers. (A) 2–
4 hours after injection of freshly prepared Wild Type Ab (1–40), discrete oligomeric aggregates of Wild Type Ab (1–40) appeared on the bilayer.
Zoomed in examples of oligomers are shown. (B–D) After ,9–12 hours, fibrils associated with vast regions of bilayer disruption were observed.
doi:10.1371/journal.pone.0016248.g004

these fibrils displayed straight morphologies reminiscent of those
observed for Wild Type Ab (1–40) (Fig. 5C), elongated aggregates
displaying enhanced curvature were frequently observed for Arctic
Ab (1–40) (Fig. 5D). These highly curved extended aggregates
often circled back upon themselves, forming large (1009s of nm
wide) ring-like structures that were not associated with the
formation of holes within the bilayer. These curved fibrillar
structures also contained many branching points, which could also

rejoin, resulting in the formation of small ring-like structures
contained within the contour of the fibril itself.
We next investigated the interaction of Italian Ab (1–40) with
supported TBLE bilayers (Fig. 6). Upon exposure of a 20 mM
solution of Italian Ab (1–40) to the TBLE bilayer, oligomeric
aggregates of similar morphology compared to those described for
Wild Type and Arctic were observed on the bilayer surface within
2–4 hours (Fig. 6A). Again, these oligomers were stable and

Figure 5. Representative in situ AFM images of Arctic Ab (1–40) aggregate formation on supported TBLE lipid bilayers. (A) When TBLE
bilayers were exposed to freshly prepared aliquots of 20 mM solution of Arctic Ab (1–40), small oligomeric aggregates were observed within 1–
2 hours. (B) After ,6–8 hours, large regions of increased bilayer roughness were observed that appeared to be co-localized with discrete oligomeric
aggregates. (C–D) Elongated fibrillar aggregates were also observed within 6–8 hours. (C) Many of these fibrils displayed straight morphologies. (D)
These fibrillar aggregates often displayed enhanced curvature, forming large circular structures with many branching points.
doi:10.1371/journal.pone.0016248.g005
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Figure 6. Representative in situ AFM images of Italian Ab (1–40) aggregate formation on supported TBLE lipid bilayers. (A) Upon
addition of a 20 mM solution of Italian Ab (1–40) to the TBLE bilayer, oligomeric aggregates appeared within 2–4 hours. (B) After ,10–12 hours of
exposure to Italian Ab (1–40), the bilayer developed large patches of increased bilayer roughness that often contained oligomeric aggregates. (B–D)
Elongated fibrillar aggregates were observed within 8–10 hours of addition of Italian Ab (1–40) to the lipid bilayer. These fibrillar aggregates
displayed a variety of morphologies, predominantly displaying large curvature and branching.
doi:10.1371/journal.pone.0016248.g006

initially increased in number with time. After ,10–12 hours of
exposure to Italian Ab (1–40), the bilayer developed large patches
of increased bilayer roughness, corresponding to disruption of the
bilayer’s structural integrity (Fig. 6B). Similar to Arctic Ab (1–40)
as opposed to Wild Type, these areas of increased bilayer
roughness were not clearly associated with rigid fibrils. However,
elongated fibrillar aggregates were observed within 8–10 hours of
addition of Italian Ab (1–40) to the lipid bilayer (Fig. 6B–D). As
was the case with Arctic Ab, these fibrillar aggregates displayed a
variety of morphologies. While several of these elongated
aggregates of Italian Ab (1–40) appeared rigid and lacking
discernable curvature, the majority of fibrillar aggregates formed
by Italian Ab (1–40) had curled morphology reminiscent of the
elongated aggregates observed for Arctic Ab (1–40). These fibrils
were often highly branched and contained a variety of large ringlike structures contained within their contour.
Upon exposure of a supported TBLE bilayer to a 20 mM
solution of Iowa Ab (1–40), a large number of discrete oligomeric
aggregates appeared on the lipid surface within 2–3 hours
(Fig. 7A). Like oligomers formed by Wild Type and other mutant
Ab (1–40) peptides, these oligomers were extremely stable and
could be imaged for several hours. In some experiments with Iowa
Ab (1–40), hole forming annular aggregates were observed with a
lip protruding ,0.5 nm above the bilayer surface and an inner
diameter of 32.764.5 nm (Fig. 7B). However, the inner diameters
of these annular aggregates were much larger than would
traditionally be considered a pore. While smaller, pore-like
structures of Ab have been reported in other studies [47,48],
these were the smallest annular structures we observed. After
,10–12 hours of exposure to Iowa Ab (1–40), the bilayer
developed small, discrete areas of disrupted lipid morphology,
i.e. enhanced roughness. These areas of enhanced roughness were
much smaller than had previously been observed for Wild Type,
Arctic, or Italian Ab (1–40) (Fig. 7C). While these small areas of
disrupted bilayer often had oligomeric structures contained within
PLoS ONE | www.plosone.org

them, there was not a significantly larger number of oligomers
associated with disruption areas compared to the number of
oligomers on intact bilayer. Many short, putative fibrillar
structures of Iowa Ab (1–40) were observed (Fig. 7C). A few
larger fibrils also appeared that were morphologically very similar
to the fibrils formed by Wild Type Ab (1–40) (Fig. 7D). These fibril
structures did not appear to be associated with changes in the
bilayer integrity. In spite of the appearance of fibrils and
oligomers, abundant larger amorphous aggregates formed from
Iowa Ab (1–40) were also present on the bilayer (Fig. 7B). While
these large amorphous aggregates extended higher above the
bilayer surface in comparison with the previously described
oligomers, they still appeared globular (round) in nature, making
them distinct from fibrils. Despite this distinctly round morphology, these amorphous aggregates often had many smaller
protofibril-like structures protruding from their periphery.
When TBLE bilayers were exposed to freshly prepared aliquots
of 20 mM solutions of Flemish Ab (1–40) via injection into the fluid
cell, oligomeric aggregates were not typically observed for 3–
5 hours (Fig. 8A). Once oligomers appeared on the surface, they
were stable for several hours. Often small bilayer defects developed
(Fig. 8B), but these defects did not appear to have any Flemish Ab
(1–40) annular aggregates associated with their appearance like the
annular hole forming aggregates observed for Iowa Ab (1–40).
After ,10–12 hours of exposure to Flemish Ab (1–40), supported
bilayers developed a few small patches of increased bilayer
roughness (Fig. 8C). These areas of increased roughness were
predominately associated with a high density of very short putative
fibrillar aggregates. However, not all fibrillar aggregates of Flemish
Ab (1–40) were associated with adjacent areas of bilayer disruption
(Fig. 8D). The fibrils not associated with bilayer disruption tended
to be isolated from other aggregate structures. In some
experiments with Flemish Ab (1–40), larger amorphous aggregates, similar to those formed by Iowa Ab (1–40), were observed
(Fig. 8B). Unlike those larger aggregates observed for Iowa Ab (1–
5
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Figure 7. Representative in situ AFM images of Iowa Ab (1–40) aggregate formation on supported TBLE lipid bilayers. (A) Upon
exposure of a supported TBLE bilayer to a 20 mM solution of Iowa Ab (1–40), a large number of discrete oligomeric aggregates appeared on the lipid
surface within 2–3 hours. (B) Hole forming annular aggregates were observed after ,6 hours. Larger amorphous aggregates formed from Iowa Ab
(1–40) were also present on the bilayer. (C) After ,10–12 hours the bilayer developed small, discrete areas of disrupted lipid morphology. Many short
putative fibrillar structures of Iowa Ab (1–40) were also observed. (D) There were some larger fibrils formed on the bilayer that were morphologically
very similar to the fibrils formed by Wild Type Ab (1–40).
doi:10.1371/journal.pone.0016248.g007

of Ab (1–40) formed in the presence of supported TBLE bilayers
(Fig. 9). To obtain data sets of physical dimensions of only globular
oligomers using our image analysis software, oligomers were
defined as any feature protruding at least 2 nm above the bilayer
surface with an aspect ratio (longest distance across to shortest
distance across) less than 2.0, indicating a globular structure.
Fibrils were defined as aggregates that protruded at least 3 nm

40), these amorphous aggregates did not appear to have smaller
protofibril-like structures protruding from their periphery.

Comparison of mutant Ab aggregate size in the presence
of lipid bilayers
We next compared measurable morphological features of
oligomer and fibrillar aggregates of Wild Type and mutant forms

Figure 8. Representative in situ AFM images of Flemish Ab (1–40) aggregate formation on supported TBLE lipid bilayers. (A) Within 3–
5 hours after the injection of Flemish Ab (1–40) into the fluid cell, oligomeric aggregates appeared on the bilayer surface. (B) Often small defects in
the lipid bilayer that did not appear to be associated with aggregates would develop. There were also many large amorphous aggregates on the
bilayer. (C) After ,10–12 hours of exposure to Flemish Ab (1–40), a few small patches of increased bilayer roughness associated with a high density
of very short putative fibrillar aggregates developed. (D) Not all fibrils were associated with bilayer disruption.
doi:10.1371/journal.pone.0016248.g008
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each mutant were in the range of 10–15 peptides per oligomer
with a mass ranging from 47–70 kDa (Fig. 9C). These measured
dimensions were within the range of a specific oligomeric structure
(Ab*56) that correlates with memory loss [50], and have been
imaged by AFM [51]. Despite the majority of these oligomers
being similar in size to Ab*56, there was still a significant number
of larger globular aggregates, particularly for the Italian and Iowa
mutants, demonstrating that the population of oligomeric
aggregates formed in the presence of lipid bilayers display
considerable heterogeneity (Fig. 9C).
The average height above the surface along the contour of
elongated, fibrillar aggregates was also determined (Fig. 9D).
Unlike the average height of oligomers, when comparing the
height of fibrils formed by mutant Ab (1–40) peptides with those
formed by Wild Type, fibrils comprised of Arctic (p,0.01) or
Italian (p,0.05) Ab (1–40) were significantly shorter based on a
student’s T-test (Fig. 9D). This suggests that fibrils formed by these
two mutant forms of Ab (1–40) are structurally different or are
further inserted into the lipid bilayer when compared to those
formed by Wild Type. Fibrils observed for Arctic and Italian Ab
(1–40) often appeared morphologically distinct to Wild Type fibrils
as described above, which supports the notion that the fibrils are

above the bilayer surface with an aspect ratio greater than 2.5,
indicating an elongated structure. These criteria were based on
measurements of representative examples of each respective
aggregate type. Measurements of oligomers and fibrils were
compiled from multiple experiments and time points. The height
(measured from the bilayer surface) distributions of globular
oligomeric aggregates were not significantly different (based on a
Spearman’s rank correlation coefficient), when comparing Wild
Type with each mutant form of Ab (1–40), suggesting that
oligomers formed from each mutation are structurally indistinguishable from those formed by Wild Type (Fig. 9A). The
similarity between oligomer aggregates formed by Wild Type and
the different mutant Ab (1–40) peptides was further illustrated by
comparison of the average height of oligomers formed by each
type of Ab (1–40) peptide (Fig. 9B). In an independent analysis, we
used the corrected volume distributions of oligomers [49] to
estimate the number of protein molecules per oligomer and the
corresponding mass of oligomers formed by Wild Type, Arctic,
Italian, Iowa, and Flemish Ab (1–40). One caveat of this analysis is
that it does not take into account any portion of the globular
oligomer that may be inserted into the bilayer. Despite this
limitation, the majority of oligomers formed by Wild Type and

Figure 9. Quantification of morphological features of aggregates formed on TBLE bilayers by Wild Type or mutant forms of Ab (1–
40). (A) Histograms of height above the bilayer surface for oligomers formed by Wild Type, Arctic, Italian, Iowa, or Flemish Ab (1–40) are shown. (B)
When the average height above the bilayer surface of oligomers formed by Wild Type and the mutant forms were compared, oligomers were not
significantly different as a function of mutation. (C) Based on corrected volume measurements and the molecular mass of Ab (1–40), the numbers of
peptides per oligomer and apparent mass of oligomers comprised of Wild Type, Arctic, Italian, Iowa, or Flemish Ab (1–40) were calculated. The plots
are color coded such that darker colors represent a greater abundance of oligomers composed of that number of molecules. Black arrows indicate
where 10–15 peptides and 47–70 kDa oligomers would be observed. (D) The average height above the bilayer surface along the contour of
elongated fibril aggregates comprised of Wild Type, Arctic, Italian, Iowa, or Flemish Ab (1–40) are shown. Fibrils formed from Arctic (* indicates
p,0.01) and Italian (** indicates p,0.05) Ab (1–40) were significantly shorter compared to fibrils comprised of Wild Type Ab (1–40). (E) Plots
correlating the contour length to the end to end distance of fibrils formed from Wild Type, Arctic, or Italian Ab (1–40) are shown. The dashed line
represents the theoretical correlation for infinitely rigid rod-like structures.
doi:10.1371/journal.pone.0016248.g009
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structurally unique. The primary morphological difference
between fibrils formed by these different versions of Ab (1–40)
was an apparent increased curvature (or reduced persistence
length) of the fibril structure. Therefore, we measured the contour
and end to end distance of individual fibrils formed from Wild
Type, Arctic, and Italian Ab (1–40) on the TBLE bilayer. We then
analyzed this data by constructing correlation plots of individual
fibril contour length as a function of their end to end distance
(Fig. 9E). For rigid structures with an infinitely large persistence
length, the contour length would be equal to the end to end
distance. For these infinitely rigid structures, the corresponding
correlation plots would produce a line with a slope of 1, which is
represented by the dashed line. As elongated fibril structures
become less rigid (shorter persistence length), correlation between
the contour length and end to end distance will deviate from this
line. As the contour length increases, the spread of the correlation
with end to end distance will increase with a decrease in
persistence length. For the more rigid fibril structures observed
for Wild Type Ab (1–40) in the presence of lipid bilayers, the
majority of data points for the correlation between contour length
and end to end distance fell near the theoretical line for an
infinitely rigid rod-like structure with very little spread (Fig. 9E).
The correlation between contour length and end to end distance
for fibrils comprised of Arctic Ab (1–40) or Italian Ab (1–40)
formed in the presence of the bilayer deviated much more from
the theoretical line with a large spread of data points with
increased contour length. These features in the correlation plots
indicate that fibrils formed from these two mutant Ab (1–40)
peptides were less rigid than their Wild Type counterparts, further
supporting that these fibrils are structurally distinct. A feature of
these plots is that for very short fibrils (contour length ,
persistence length) the data points fall very closely to the
theoretical line of infinitely rigid rods. Due to this feature, analysis
of fibrils formed from Iowa and Flemish Ab (1–40) was
inconclusive (data not shown) because the observed fibrils formed
from these peptides tended to be very short (less than 200 nm in
contour length).

Figure 10. Quantification of bilayer roughening. (A) Quantitative
assessment of bilayer disruption by analysis of root mean square (RMS)
roughness of images taken before and after exposure to various Ab (1–
40) peptides is shown. Control corresponds to RMS roughness
measurements taken on supported TBLE lipid bilayers that had not
been exposed to any Ab (1–40) peptides. Exposure to Wild Type, Arctic,
Italian, Iowa, or Flemish Ab (1–40) induced significant (* indicates
p,0.01) roughening of the supported TBLE lipid bilayer. RMS
roughness measurements of disrupted areas were restricted to areas
that displayed enhanced roughness to prevent biased based on the
extent of disruption. (B) The percent area of TBLE bilayers containing
increased roughness induced by exposure to Wild Type, Arctic, Italian,
Iowa, or Flemish Ab (1–40) was measured from images obtained 10–
12 hours after the initial injection of Ab (1–40) peptides. Exposure to
Arctic Ab (1–40) resulted in a significantly larger area of the bilayer
being disrupted in comparison to Wild Type (* indicates p,0.01). The
extent of bilayer disruption was significantly reduced when bilayers
were exposed to Iowa or Flemish Ab (1–40) in comparison to Wild Type
(** indicates p,0.05).
doi:10.1371/journal.pone.0016248.g010

lack thereof) being associated with regions of bilayer disruption for
Wild Type or mutant forms of Ab (1–40), there was no significant
differences in the measured RMS roughness of these regions when
comparing each mutant peptide to Wild Type.
Although the resulting surface roughness associated with bilayer
disruption by Wild Type or mutant forms of Ab (1–40) was similar
in magnitude after 10 hours of exposure, the fraction of the bilayer
surface area exhibiting some amount of increased roughness
varied (Fig. 10B) (which is one reason why the RMS roughness
measurements reported above were taken over different sized
areas). For Wild Type Ab (1–40), 25.469.0% of the bilayer surface
area exhibited increased surface roughness. The Arctic mutation
significantly (p,0.01) increased the percent area of bilayer
disruption (41.0610.9%) after 8 hours of co-incubation. Despite
resulting in morphologically distinct fibrillar aggregates, the Italian
mutation did not result in a significantly different percent of
bilayer surface area with increased roughness (24.369.4%) in
comparison to Wild Type. Both the Iowa (14.32610.0%) and
Flemish (11.269.4%) mutations resulted in a significantly
(p,0.01) smaller percentage of the bilayer being disrupted in
comparison to Wild Type.

Comparison of induced lipid roughness by different
point mutations of Ab
We next used image processing software to analyze the extent of
bilayer disruption. A freshly formed bilayer had a root mean
square (RMS) surface roughness of 0.2460.09 nm measured over
a total of 148 mm2 (Fig. 10A). To prevent error associated with the
size of the regions of disrupted bilayer structure, RMS roughness
measurements of areas that had been destabilized by Ab (1–40)
and mutant Ab (1–40) peptides were restricted only to portions of
the images containing disrupted regions, excluding regions of the
bilayer not altered by the presence of Ab (1–40) from the analysis.
RMS roughness measurements are also highly dependent on the
coverage of Ab (1–40) aggregates present on the surface; therefore,
aggregate structures were filtered out of the analysis. All RMS
measurements were taken from images representing at least 10–
12 hours of bilayer exposure to Wild Type or mutant forms of Ab
(1–40). After 10 hours of exposure to Wild Type Ab (1–40),
disrupted portions of the bilayer surface displayed significantly
(p.0.01) enhanced RMS surface roughness increasing to
1.1860.46 nm measured over a total of 56.7 mm2 (Fig. 10A).
Likewise, significant (p.0.01) bilayer roughening occurred after
10 hours of exposure to all mutant Ab (1–40) peptides
(1.5560.19 nm measured over 1,579 mm2, 1.4160.24 nm measured over 896 mm2, 1.8660.46 nm measured over 117 mm2,
1.6060.27 nm measured over 381 mm2 for Arctic, Italian, Iowa,
and Flemish respectively). Despite different aggregate types (or
PLoS ONE | www.plosone.org

Discussion
In this study we compared the interaction of Wild Type, Arctic,
Italian, Iowa, and Flemish Ab (1–40) peptides with supported
TBLE lipid bilayers with a focus on aggregate morphology and
bilayer disruption. Point mutations have been shown to promote
protein aggregation by destabilizing the native, globular state of a
protein [52]. While it has already been demonstrated that these
specific point mutations alter the rate of Ab aggregation
[29,30,31,32,33,51,53,54], we demonstrate here that these mutations result in a heterogeneous mixture of aggregate species and
8
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polymorphic fibrillar structures, especially in the presence of lipid
bilayers. Furthermore, the ability of Ab to disrupt the structural
integrity of bilayers is notably modulated by these mutations.
Results presented here highlight the potential role electrostatic
and hydrophobic properties of Ab play in its ability to bind, insert,
and potentially disrupt lipid membranes. The Arctic mutation
replaces a polar, negatively charged glutamic acid with a nonpolar,
neutral glycine. The Arctic mutation also represents a change in
the hydropathy index [55] from 23.5 to 20.4, increasing the
hydrophobic nature of the peptide. We speculate that the resultant
increased hydrophobic nature increases the insertion of Arctic Ab
(1–40) once bound to the bilayer surface leading to enhanced
bilayer disruption. The observed enhanced bilayer disruption at
micromolar concentrations is consistent with recent coarse-grained
molecular dynamic simulations of fibril-forming amphipathic
peptides in the presence of lipid vesicles suggesting that the
ongoing process of aggregation leads to the development of defects
in the bilayer surface, underlying the ability of mutations that
enhance fibrillogenesis to appear more toxic [18]. The Italian
mutation replaces a polar, negatively charged glutamic acid
residue with a polar, positively charged lysine, with a corresponding small decrease in hydrophobic character (hydropathy index
changes from 23.5 to 23.9). Despite the Italian mutation being
associated with an increased rate of aggregation [41], the extent of
bilayer disruption did not significantly change in comparison with
Wild Type Ab (1–40). However, fibril morphologies observed for
the Italian mutation in the presence of the lipid bilayer (as will be
discussed in more detail later) were morphologically distinct
compared to Wild Type fibrils. The Iowa mutation replaces a
polar, negatively charged aspartic acid with a polar, neutral
asparagine; however, there is no change in the hydrophobic
character of the peptide based on the hydropathy index. As the
Iowa mutation does not alter the hydrophobic character of Ab (1–
40), the reduced ability of the Iowa mutation to disrupt supported
lipid bilayers appears to be related to eliminating a negative charge
from the peptide. The Arctic mutation also resulted in the
elimination of a negative charge from Ab (1–40); however as
previously stated, the Arctic mutation resulted in increased bilayer
disruption due to its increased hydrophobic character. The
Flemish mutation replaces a nonpolar, neutral alanine residue
with a nonpolar, neutral glycine, leading to a large decrease in
hydrophobic character (a change of 1.8 to 20.4 in the hydropathy
index). As there is no net change in peptide charge, the decreased
extent of aggregation and bilayer disruption observed for the
Flemish mutation is most likely a result of its increased hydrophilic
nature. Interestingly, it has often been observed that exogenously
added Ab will selectively bind a subset of hippocampal neurons
and neuroblastoma cells in culture [56,57]. These selective
interactions could potentially be regulated by not only the
composition of the cellular membrane but also by the electrostatic
and hydrophobic properties of Ab, which is supported by the
altered aggregation patterns observed for different mutant
peptides.
The central peptide region, where the mutations studied here
are located, has been implicated as being important in Ab
aggregation and fibril structure. EPR studies of Ab fibril structure
using site-directed spin-labeling demonstrated that this central
region is sandwiched between two more highly ordered regions in
the fibril structure [58]. Later studies using systematic proline
replacement in Ab (1–40) demonstrated that residues 22 and 23
probably occupy turn positions within the fibril structure [59].
Interestingly, these mutations are located at the end of or directly
adjacent to a sequence in Ab (residues 16–21) that has been
identified to be highly amyloidogenic [43], indicating that this
PLoS ONE | www.plosone.org

region may be a viable target for preventing Ab aggregation for
therapeutic purposes. In this regard, several antibodies and single
chain variable fragments specific for this region of Ab appear to
prevent aggregation and in some cases reduce toxicity [60,61,62].
As each mutation alters aggregation kinetics as well as AD
phenotype, each may have different propensities to form various
abnormal structures like spherical oligomers, and this may be
heavily influenced by the chemical environment or liquid/solid
interfaces. Observations reported here support the notion that this
region plays a role in lipid/Ab interactions that can influence
aggregate morphology and the ability of Ab to disrupt bilayer
integrity. In particular, the propensity to form polymorphic
fibrillar structures on lipid bilayers appears to be heavily
influenced by point mutations in this region.
A striking feature of many amyloid forming peptides is their
ability to form more than one stable fibril structure [4]. The
fibrillar aggregates formed by the Arctic and Italian Ab (1–40)
peptides in the presence of the supported lipid bilayers appeared to
be distinct polymorphs compared to those formed by the Wild
Type peptide. This observation suggests that electrostatic and
hydrophobic interactions with membrane surface can induce
polymorphic aggregate structures of Ab. In the case of the Arctic
mutation, it has been reported that aggregates (oligomer,
protofibrils, and fibril) formed by this mutation are indistinguishable to those formed by Wild Type under free solution conditions
[51]. However, the aggregation process and resulting aggregate
morphology of Arctic differed dramatically in comparison to Wild
Type in the presence of the anionic surface of mica, pointing to the
ability of surfaces to influence aggregate structure [51]. This ability
of surfaces to alter aggregate morphology of amyloidogenic
peptides has been well documented for a variety of systems
[63,64]. It appears that the chemical environments provided by
lipid membranes have the ability to structurally influence the
aggregation of Ab into elongated structures. The two mutations
that led to shorter, less rigid fibril structures both occur at the 22nd
residue of Ab. In both cases, a negative charge is removed,
indicating that this residue may experience specific electrostatic
interactions with lipids that influence its ability to form distinct
fibrillar polymorphs. However, it appears that the exact
composition of the bilayer and the peptide preparation protocol
could also play a role in this interaction, as the more highly curved
fibril structures have been observed for Wild Type Ab (1–40) on
TBLE bilayers by other investigators [15]. The Iowa and Flemish
mutations did not appear to result in different morphologies of
fibrils compared to Wild Type; however, the extent of fibril
formation appeared to be reduced in the presence of the bilayer by
both of these mutations. As it has been proposed that different
polymorphs may be associated with variations in AD phenotype
[9], it is tempting to speculate that local chemical environments of
lipid membranes may influence the aggregate state of Ab.
Furthermore, the propensity of mutant Ab to form different
polymorphic aggregates may underlie the phenotypic variations
associated with these mutations.

Materials and Methods
Sample preparation
Synthetic Wild Type, Arctic, Italian, Iowa, and Flemish Ab (1–
40) peptides were obtained from AnaSpec Inc. (San Jose, CA). All
peptides were prepared in the same manner [44]. In short,
peptides were treated with Hexafluoroisopropanol (HFIP) to
dissolve pre-existing aggregates. The HFIP was evaporated off in
a Vacufuge concentrator (Eppendorf), resulting in a small peptide
film. These peptide films were dissolved in dimethyl sulfoxide
9
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(DMSO) to make a 2000 mM stock solution. These stock solutions
were then dissolved directly into 37uC PBS buffer (pH 7.3) to a
final concentration of 20 mM (final DMSO concentration of 1%).
Total brain lipid extract (porcine) was purchased from Avanti
Polar Lipids (Alabaster, AL) in a lypholized state and was
resuspended in PBS (pH 7.3) at a concentration of 1 mg/ml.
Using an acetone/dry ice bath, bilayers and multilayer lipid sheets
were formed by five cycles of freeze-thaw treatment [15,16]. The
lipid suspensions were then sonicated for 15 minutes to promote
vesicle formation. All experiments were performed with the same
lot of lipids.

position within the image, etc.) were automatically measured.
Each aggregate was also assigned an individual number so that
aggregates chosen based on specific measured properties could be
located, allowing us to verify that chosen dimensions corresponded
to specific aggregate types. In this way large data sets were
automatically constructed that could be used to keep track of
thousands of individual aggregates and sorted based on specific
dimensional characteristics. Based on inspection of individual
representative aggregate types and verified using our tracking
system, we assigned specific dimensional characteristics to specific
aggregate types. Oligomers were defined as 2–10 nm in height
with an aspect ratio (longest distance across to shortest distance
across) less than 2, indicating a globular structure. Fibrils were
defined as aggregates greater than 3 nm in height that had an
aspect ratio greater than 2.5. For determination of fibril contour
length and end to end distance, individual objects in an AFM
image were identified by height thresholding and filtering based on
aspect ratio. The software then incorporated a fast parallel
thinning algorithm [65] to create a pixel skeleton for each object
present in the AFM image. Once the fibril skeleton was obtained,
the endpoints of each skeleton were determined and used to
calculate end to end distance. The pixel skeleton was used to
determine contour length and average height along contour of the
fibril.

AFM imaging conditions
In situ AFM experiments were performed with a Nanoscope V
MultiMode scanning probe microscope (Veeco, Santa Barbara,
CA) equipped with a sealable fluid cell and a closed-loop vertical
engage J-scanner. Images were taken with V-shaped oxidesharpened silicon nitride cantilever with a nominal spring constant
of 0.5 N/m. Scan rates were set at 1 to 2 Hz with cantilever drive
frequencies ranging from ,8–10 kHz. Concentrated TBLE
vesicle solution was added to the cell in 40 mL aliquots by the
hanging drop method and allowed to fuse in situ. Once a
40640 mm patch of defect-free bilayer was formed, the cell was
flushed to remove vesicles remaining in solution. Only defect-free
bilayers that were 40640 mm were used for studies with Ab. Next,
40 mL of 20 mM of freshly prepared Ab (1–40) solution in PBS was
added via the channels in the fluid cell.

Determining the number of peptides per oligomer from
AFM images
Volume measurements were partially corrected for error
associated with the finite size of the AFM probe based on
geometric models [49]. The volume of an individual Ab peptide
was estimated based on its molecular weight and the average
density of proteins [66,67]. By dividing the observed corrected
volume of each individual aggregate by the estimated volume of a
single monomer, the number of molecules per each oligomer was
calculated. This calculation assumes perfect packing of individual
monomers within the oligomer and that the density of the proteins
is the same in aggregated and unaggregated forms.

Quantitative analysis of AFM images
Image analysis of all AFM images was performed using Matlab
equipped with the image processing toolbox (Mathworks, Natick,
MA). Physical dimensions of most aggregates were measured
automatically in this way: 1) Images were imported into Matlab. 2)
Images were flattened to correct for curvature due to the imaging
process. 3) Flattened images were converted into binary maps of
aggregate locations by using a height threshold (set at ,1 nm).
This was accomplished by assigning values of 1 to any pixel of the
image that represented a height above the threshold and assigning
a value of 0 to any pixel corresponding to a height below the
threshold. 4) The binary map was used to locate aggregates within
the original AFM image using pattern recognition algorithms. 5)
Once a discreet aggregate was located, dimensions (including
height, volume, average diameter, width, length, aspect ratio,
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